Japanese pharmaceutical major Daiichi Sankyo has said that it will extend assistance to Ranbaxy’s plants in India hit by US quality sanctions to upgrade their standard. In a meeting with Commerce & Industry Minister Anand Sharma on Thursday, Daiichi Sankyo’s President & CEO, George Nakayama, said that the company will give technical assistance to Ranbaxy to comply with norms, according to a Commerce Ministry official. Daiichi, which owns a controlling stake in Ranbaxy, will focus on the company’s plant in Mohali which is the latest to be hit by US FDA sanctions following which exports from the unit to the US has been banned.
Help employers find you! Check out all the jobs and post your resume.
